HUM vs IPSC · P/E 39, rev $129.66B vs rev $6.6M
Humana Inc (HUM) versus Century Therapeutics Inc (IPSC) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Century Therapeutics Inc (IPSC) is a biotechnology company listed on US.
Latest reported HUM revenue for 2025-12-31 was $129.66B. Net income was $1.19B. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported IPSC revenue for 2024-12-31 was $6.6M. Net income was -$126.6M. Revenue was up 194.8% from 2023-12-31 to 2024-12-31. IPSC currently screens at market cap $47.8M.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. IPSC currently screens at market cap $47.8M.
Not investment advice. Open the HUM and IPSC stock pages for the full models.
Not investment advice.